(Q43923526)

English

High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

liver cirrhosis

0 references

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ishikawa T

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ichida T

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Yamagiwa S

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sugahara S

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Uehara K

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Okoshi S

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Asakura H

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1274-1281

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hepatocellular carcinoma. A worldwide problem and the major risk factors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Characteristics of patients with dual infection by hepatitis B and C viruses

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02616.X

21 January 2018

Identifiers

10.1046/J.1440-1746.2001.02616.X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43923526&oldid=2104418655"